Key Market Indicators
The Lithuanian Diagnostic Reagent market is expected to reach €393 million by 2026, growing 4.4% year on year on average. Since 2010, the market has seen a 24.4% year on year increase. In 2021, Lithuania was the 6th largest market for diagnostic reagents, with Spain taking the lead at €297 million. The United Kingdom, Ireland and Sweden ranked 2nd, 3rd and 4th respectively. Exports of Lithuanian diagnostic reagents are set to reach $617 million by 2026, growing 4.2% year on year on average. Since 1999, exports have increased by 22.8% year on year. In 2021, Lithuania was 15th in the ranking, with South Korea taking the lead at $473 million. Germany, the Netherlands and the United Kingdom ranked 2nd, 3rd and 4th respectively. Imports of Lithuanian diagnostic reagents are set to reach $173 million by 2026, growing 3.4% year on year on average. Since 1999, imports have risen 15% year on year. In 2021, Lithuania was 39th in the ranking, with Israel taking the lead at $139 million. Germany, China and the Netherlands ranked 2nd, 3rd and 4th respectively.
